Patents
Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
01/2014
01/15/2014CN103509021A Cytisine derivative, its preparation method and anticancer effect research
01/15/2014CN103509016A Bipyridine fluorene derivatives, preparation method and application thereof, and electroluminescent device
01/15/2014CN102276514B Fluorene-bridged blue phosphorescent main body material and preparation method and application thereof
01/09/2014WO2013124026A8 8 - substituted 2 -amino - [1,2,4] triazolo [1, 5 -a] pyrazines as syk tryrosine kinase inhibitors and gcn2 serin kinase inhibitors
01/08/2014EP2681214A1 Bridged piperidine derivatives
01/08/2014EP2283021B1 Switchable special effect substances
01/08/2014CN103502252A Novel compound, charge transport material, and organic device
01/08/2014CN103502247A 7-azaindole derivatives
01/08/2014CN103502233A Novel compound, material for organic electroluminescence device, and organic electroluminescence device
01/08/2014CN103497207A Biapenem B-type crystals
01/08/2014CN103497185A Pyrazolo(3, 4-B)pyridine derivatives as phosphodiesterase inhibitors
01/03/2014WO2014001973A1 NOVEL 4-(SUBSTITUTED-AMINO)-7H-PYRROLO[2,3-d]PYRIMIDINES AS LRRK2 INHIBITORS
01/03/2014CA2878054A1 Novel 4-(substituted-amino)-7h-pyrrolo[2,3-d]pyrimidines as lrrk2 inhibitors
01/02/2014US20140005183 Novel 4-(Substituted Amino)-7H-Pyrrolo[2,3-d] Pyrimidines As LRRK2 Inhibitors
01/02/2014US20140005182 Aryl Methyl Benzoquinazolinone M1 Receptor Positive Allosteric Modulators
01/01/2014EP2678329A1 Triazolopyridine compounds as pim kinase inhibitors
01/01/2014CN103493239A Organic electroluminescent element
01/01/2014CN103492390A Fluorophenyl bicyclic heteroaryl compounds
01/01/2014CN103492389A Pyrazolo [4, 3-d] pyrimidines useful as kinase inhibitors
01/01/2014CN103492388A Pyrazolospiroketone derivatives for use as acetyl-coa carboxylase inhibitors
01/01/2014CN103492383A Materials for organic electroluminescent devices
01/01/2014CN103492377A Triazolopyridine compounds as PIM kinase inhibitors
01/01/2014CN103483560A 2,1,3-benzothiadiazole thiophene derived bromide and carbazole conjugated polymer and synthesis method thereof
01/01/2014CN103483559A Conjugated polymer based on 2,1,3-diazosulfide 2'-bithiophene derivative and synthesis method thereof
01/01/2014CN103483557A Dithienobenzene polymers, and preparation method and application thereof
01/01/2014CN103483358A Method for producing neem crude drug by extracting neem with supercritical CO2
01/01/2014CN102633995B Synthesis method for narrow-bandgap polythiophene derivative
12/2013
12/27/2013WO2013189237A1 Andrographolide analogue and application of andrographolide analogue to treatment
12/27/2013CA2877089A1 Novel 2,3-dihydro-1h-imidazo{1,2-a}pyrimidin-5-one and this1,2,3,4-tetrahydropyrimido{1,2-a}pyrimidin-6-one derivatives comprising a substituted morpholine, preparation thereof and pharmaceutical use thereof
12/26/2013US20130345197 Azaindoles useful as inhibitors of jak and other protein kinases
12/26/2013US20130345123 Substituted adipic acid amides and uses thereof
12/25/2013EP2677560A1 Organic electroluminescence element and illumination device
12/25/2013EP2676958A1 N1-Pyrazolospiroketone acetyl-CoA carboxylase inhibitors
12/25/2013EP2675481A1 Cytotoxic benzodiazepine derivatives and methods of preparation
12/25/2013EP2675480A1 Methods of preparation of conjugates
12/25/2013EP2675479A1 Cytotoxic benzodiazepine derivatives
12/25/2013EP2483278B1 Benzoxazepin pi3k inhibitor compounds and their use in the treatment of cancer
12/25/2013CN103476823A Conjugated polymers
12/25/2013CN103476767A Heterocyclic compounds as PI3 kinase inhibitors
12/25/2013CN103467711A Bi-thiophene oxindolyl semiconductor polymer, and preparation and application thereof
12/25/2013CN103467482A Condensed pyrimidine compound, and preparation method, intermediate, composition and application thereof
12/25/2013CN103467481A Dihydropyridine compounds, compositions thereof, preparation method and applications
12/19/2013WO2013186187A1 Proof of the viability of biological specimens
12/18/2013EP2674430A1 Amino group-containing pyrrolidinone derivative
12/18/2013EP2673269A1 Heterocyclic compounds as pi3 kinase inhibitors
12/18/2013CN103459388A Novel furanone derivative
12/18/2013CN103450890A Fluorescent chemical sensor and manufacturing method thereof
12/18/2013CN103450227A Neem active compound and insecticide containing neem active compound as well as preparation method and application of neem active compound
12/18/2013CN103450226A Organic electrochromic stealth material and application thereof
12/18/2013CN103450204A Pyrrole [2,1-f][1,2,4] triazine compound, and preparation method and purpose thereof
12/12/2013WO2013182847A1 Organic electron acceptor compounds
12/12/2013US20130331374 Protein Kinase C Inhibitors and Uses Thereof
12/12/2013US20130331349 Compositions and methods for modulating fxr
12/11/2013EP2670748A2 7-azaindole derivatives
12/11/2013CN103435784A Benzodithiophene-like polymer as well as preparation method and application thereof
12/11/2013CN103435633A Psychotridine extracting method
12/11/2013CN103435616A D(A-Ar)n type compound and application thereof
12/11/2013CN102617610B Preparation method of porphyrin photosensitizer and anticarcinogen diad
12/11/2013CN102584861B Diarrhetic shellfish poison standard sample as well as preparation method and application thereof
12/10/2013CA2767664C Compounds and compositions for the treatment of parasitic diseases
12/05/2013WO2013179645A1 Organic-electroluminescent-element material, and organic electroluminescent element using same
12/05/2013WO2013178021A1 Pyrrole [2, 1-f][1, 2, 4] triazine derivative and antitumor effect thereof
12/05/2013WO2013177983A1 Pyrrolo[2,1-f][1,2,4]triazine compound, and preparation method and application thereof
12/04/2013EP2542556B1 Compounds of dibenzylidene sorbitol ester type, process of preparation, use, compositions comprising them and cosmetic treatment method
12/04/2013CN103421028A Vinorelbine derivative, medicine composition thereof, and preparation method and application of derivative and medicine composition
12/04/2013CN103421027A Preparation method and application method of diazabicyclo compound
12/04/2013CN103421005A Acetylene derivative capable of resisting activity of tumor
12/04/2013CN102300865B Dimeric pyrrolopyrimidinedione and its use in therapy of respiratory diseases
11/2013
11/28/2013WO2013174744A1 Thienopyrimidines
11/28/2013WO2013152065A3 1,8-naphthyridin-2(1h)-one derivatives as cytomegalovirus inhibitors
11/27/2013EP2666774A1 Beta-lactamase Inhibitors
11/27/2013CN103405431A Opioid and opioid-like compounds and uses thereof
11/26/2013US8590233 Stacking wall panel system and methods of installation and use
11/21/2013WO2013172225A1 Method for manufacturing transparent electrode
11/21/2013WO2013171157A1 Method for producing recombinant 11-de-o-methyltomaymycin
11/21/2013WO2013170719A1 Vinorelbine derivatives, pharmaceutical composition, preparation method therefor and application thereof
11/21/2013US20130310391 7-azaindole derivatives
11/20/2013EP2663565A2 Heteroaryl compounds and methods of use thereof
11/20/2013EP2430022B1 1,2,4-Triazolo[4,3-a]pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
11/20/2013EP2205610B1 Thienopyrimidiene derivatives as pi3k inhibitors
11/20/2013EP2146572B1 Bicyclic anilide heterocyclic cgrp receptor antagonists
11/20/2013CN103403010A Inhibitors of polo-like kinase
11/20/2013CN103403003A Bridged piperidine derivatives
11/20/2013CN102131807B Pyrazolopyridine kinase inhibitors
11/20/2013CN102056899B Polycyclic compound and organic electroluminescent device using the same
11/20/2013CN101952295B Pyrrolopyrazine kinase inhibitors
11/14/2013WO2013168807A1 Additive for graft cell suspension, and therapeutic composition
11/14/2013WO2013168759A1 Aromatic ring compound
11/13/2013EP2662378A1 Imide compound, method for producing same, thickening agent for grease, and grease composition
11/13/2013CN103391924A Novel antiviral compounds
11/13/2013CN102268024B Novel crystal form of biapenem and synthetic method thereof
11/13/2013CN101868464B Thienopyrimidiene derivatives as PI3k inhibitors
11/13/2013CN101506207B Compound having pyridoindole ring structure having substituted pyridyl group attached thereto, and organic electroluminescence element
11/12/2013CA2651206C Bivalent smac mimetics and the uses thereof
11/07/2013US20130296319 N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS
10/2013
10/31/2013WO2013163279A1 Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation
10/31/2013WO2013163244A1 Imidazothiadiazole derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation
10/31/2013WO2013163241A1 Imidazothiadiazole and imidazopyridazine derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation
10/30/2013EP2655314A1 Multi- api loading prodrugs
10/30/2013CN103374022A 低聚噻吩衍生物及其制备方法 Oligothiophene derivative and preparation method
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 ... 111